KidneyIntelX
The partnership with the Joslin Diabetes Center will add a panel of novel biomarkers to the indicators currently captured by KidneyIntelX.
Artificial intelligence-enabled in vitro diagnostics company Renalytix AI announced today a research partnership with AstraZeneca to develop and launch medical strategies for cardiovascular, renal and metabolic diseases.